Serum transferrin saturation, stroke incidence, and mortality in women and men: The NHANES I epidemiologic followup study

American Journal of Epidemiology

Volumn 144, Issue 1, 1996, Pages 59-68

  Gillum, Richard F ^a   Sempos, Christopher T ^a   Makuc, Diane M ^a   Looker, Anne C ^a   Chien, Chia Ying ^a   Ingram, Deborah D ^a  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

blacks; cerebral embolism and thrombosis; cerebrovascular disorders; cohort studies; ferritin; free radicals; iron; transferrin

Indexed keywords

TRANSFERRIN;

ADULT; AGED; ARTICLE; BRAIN EMBOLISM; FEMALE; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON TRANSPORT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK ASSESSMENT; STROKE; TRANSFERRIN BLOOD LEVEL;

EID: 0029995905     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008855     Document Type: Article

References (55)

1. Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 330:1119-24.
2. Ascherio A, Willett WC. Are body iron stores related to the risk of coronary heart disease? (Editorial). N Engl J Med 1994;330:1152-4.
3. Gillum RF, Feinleib M. Cardiovascular disease in the United States: mortality, prevalence and incidence. In: Kapoor AS, Singh BM, eds. Prognosis and risk assessment in cardiovascular disease. New York, NY: Churchill Livingstone, 1993: 49-59.
4. Miller HW. Plan and operation of the Health and Nutrition Examination Survey, United States, 1971-73. Hyattsville, MD: National Center for Health Statistics, 1978. (DHEW publication no. (PHS) 79-1310).
5. Engel A, Murphy RS, Maurer K, et al. Plan and operation of the HANES I Augmentation Survey of Adults 25-74 Years, United States, 1974-75. Hyattsville, MD: National Center for Health Statistics, 1978. (DHEW publication no. (PHS) 78-1314).
6. Cohen BB, Barbano HE, Cox CS, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1982-84. Hyattsville, MD: National Center for Health Statistics, 1987. (DHHS publication no. (PHS) 87-1324).
7. Cox CS, Rothwell ST, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1987. Hyattsville, MD: National Center for Health Statistics. 1992. (DHHS publication no. (PHS) 92-1303).
8. Madans JH, Kleinman JC, Cox CS, et al. Ten years after NHANES I: report of initial follow-up, 1982-84. Public Health Rep 1986;101:465-73.
9. Madans JH, Cox CS, Kleinman JC, et al. Ten years after NHANES I: mortality experience at initial follow-up, 1982-84. Public Health Rep 1986;101:474-81.
10. White LR, Losonczy KG, Wolf PA. Cerebrovascular disease. In: Cornoni-Huntley JC, Huntley RR, Feldman JJ, eds. Health status and well-being of the elderly. New York: Oxford University Press, 1990:115-35.
11. Finucane FF, Madans JH, Bush TL, et al. Decreased risk of stroke among postmenopausal hormone users: results from a national cohort. Arch Intern Med 1993;153:73-9.
12. US Department of Health, Education and Welfare. HANES I hematology and clinical chemistry procedures developed or utilized by the Centers for Disease Control, Bureau of Laboratories, 1971-75. Hyattsville, MD: National Center for Health Statistics, 1979.
13. Fulwood R, Abraham S, Johnson CL. Serum cholesterol levels of persons 4-74 years of age by socioeconomic characteristics, United States, 1971-74. Hyattsville, MD: National Center for Health Statistics, 1980. (DHHS publication no. (PHS) 80-1667).
14. Singer JD, Granahan P, Goodrich NN, et al. Diet and iron status: a study of relationships, United States, 1971-74. Hyattsville, MD: National Center for Health Statistics, 1982. (DHHS publication no. (PHS) 83-1679).
15. Looker AC, Sempos CT, Liu KA, et al. Withinperson variance in biochemical indicators of iron status: effects on prevalence estimates. Am J Clin Nutr 1990;52:541-7.
16. Technicon autoanalyzer methodology. AA 11-25. Tarrytown, NY: Technicon Instruments Corp., September 1971.
17. Giovanniello TJ, Bendetto G, Palmer DW, et al. Fully and semiautomated methods for the determination of serum iron and total iron-binding capacity. J Lab Clin Med 1968;71: 874-80.
18. Ramswey WNM. The determination of the total iron-binding capacity of serum. Clin Chim Acta 1957;2:221-4.
19. Doumas BT, Watson WA, Biggs HC. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971;31:87-95.
20. Eavenson E, Grier OT, Cisson TG, et al. A semi-automated procedure for the determination of serum cholesterol using the Abell-Kendall method. J Am Oil Chem Soc 1970;43:652-6.
21. Abell LL, Levy BB, Brodie BB, et al. A simplified method for the estimation of serum cholesterol in serum and demonstration of its specificity. J Biol Chem 1952;195:357-66.
22. Abraham S, Johnson CL, Carroll MD. Total serum cholesterol levels in adults 18-74 years: United States, 1971-74. Hyattsville, MD: National Center for Health Statistics, 1978. (DHEW publication no, (PHS) 79-1652).
23. Wintrobe MM, Landsberg JW. A standardized technique for blood sedimentation test. Am J Med Sci 1935;189:102-15.
24. Roberts J, Maurer K. Blood pressure levels of persons 6-74 years, United States, 1971-74. Hyattsville, MD: National Center for Health Statistics, 1977. (DHEW publication no. (PHS) 78-1648).
25. McLaughlin JK, Dietz MS, Mehl ES, et al. Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol 1987;126:144-6.
26. Machlin SR, Kleinman JC, Madans JH. Validity of mortality analysis based on retrospective smoking information. Stat Med 1989;8:997-1009.
27. Miles LEM, Lipschitz DA, Bieber CP, et al. Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 1974;61:209-24.
28. McDowell A, Engel A, Massey JT, et al. Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-80. Hyattsville, MD: National Center for Health Statistics, 1981. (DHHS publication no. (PHS) 81-1317).
29. Harrell FE Jr. The PHGLM procedure. In Hastings RP, ed. SUGI supplemental library user's guide, version 5. Cary, NC: SAS Institute, Inc., 1986:437-74.
30. Software for survey design analysis (SUDAAN), version 5.30. Research Triangle Park, NC: Research Triangle Institute, 1992.
31. Holt MM, Shah BV. SURREGR: standard errors of regression coefficients from sample survey data. Research Triangle Park, NC: Research Triangle Institute, 1982:1-14.
32. Clayton D, Mills M. Statistical methods in epidemiology. London: Oxford University Press, 1993:249-60.
33. Terada LS, Willingham IR, Repine JE. Iron and stroke. In: Lauffer RB. Iron and human disease. Boca Raton, FL: CRC Press, 1992:313-29.
34. Davalos A, Fernandez-Real JM, Ricart W, et al. Iron-related damage in acute ischemic stroke. Stroke 1994;25:1543-6.
35. Miller M, Hutchins GM. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. JAMA 1994;272: 231-3.
36. Rauramaa R, Vaisanen S, Mercuri M, et al. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men. Eur Heart J 1994; 15: 1020-7.
37. Moore M, Folsom AR, Barnes RW, et al. No association between serum ferritin and asymptomatic carotid atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1995;141:719-23.
38. Kiechl S, Aichner F, Gerstenbrand F, et al. Body iron stores and presence of carotid atherosclerosis: results from the Bruneck Study. Arterioscler Thromb 1994;14:1625-30.
39. Herbert V, Shaw S, Jayatilleke E, et al. Most free-radical injury is iron-related: It is promoted by iron, hemin, holoferritin, and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 1994; 12:289-303.
40. Magnusson MK, Sigfusson N, Sigvaldason H, et al. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-8.
41. Gillum RF, Makuc D. Serum albumin, coronary heart disease, and death. Am Heart J 1992;123:507-13.
42. Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994;140:876-88.
43. Kushner JP. Normochromic, normocytic anemias. In: Wyngaarden JB, Smith LH Jr. eds. Cecil textbook of medicine. Philadelphia, PA: WB Saunders Company, 1988: 890-900.
44. Kannel WB, Gordon T, Wolf PA, et al. Hemoglobin and risk of cerebral infarction: the Framingham Study. Stroke 1972;3: 409-20.
45. Campbell MJ, Elwood PC, Mackean J, et al. Mortality, haemoglobin level and haematocrit in women. J Chron Dis 1985; 38:881-9.
46. Gagnon DR, Zhang T, Brand FN, et al. Hematocrit and the risk of cardiovascular disease - the Framingham Study: a 34-year follow-up. Am Heart J 1994;127:674-82.
47. Tohgi H, Yamanouchi H, Ogawa M, et al. The risk factors for cerebrovascular disease in the aged. Jpn J Med 1978;17:9-14.
48. Lowe GDO, Jaap AJ, Forties CD. Relation of atrial fibrillation and high haematocrit to mortality in acute stroke. Lancet 1983;l:784-6.
49. Gray CS, French JM, James OFW, et al. The prognostic value of haematocrit in acute stroke. Age Ageing 1983;17:406-9.
50. Woo J, Lau E, Kay R, et al. A case control study of some hematological and biochemical variables in acute stroke and their prognostic value. Neuroepidemiology 1990;9:315-20.
51. Kiyohara Y, Ueda K, Hasuo Y, et al. Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community. Stroke 1986;17: 687-92.
52. Kagan A, Popper JS, Rhoads GG. Factors related to stroke incidence in Hawaii Japanese men: the Honolulu Heart Study. Stroke 1980;11:14-21.
53. Wannamethee G, Perry IJ, Shaper AG. Haematocrit, hypertension and risk of stroke. J Int Med 1994;235:163-8.
54. Gordeuk VR, Body RD, Brittenham GM. Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1986;1: 1310-13.
55. Report of the National Institutes of Health: opportunities for research on women's health. Washington, DC: GPO, 1992: 29-30. (NIH publication no. 92-3457).